Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study

BACKGROUND: Hydroxyurea therapy is effective for reducing complications related to sickle cell disease (SCD) and is recommended by National Health Lung and Blood Institute care guidelines. However, hydroxyurea is underutilized, and adherence is suboptimal. We wanted to test a multilevel mobile healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Badawy, Sherif M, DiMartino, Lisa, Brambilla, Donald, Klesges, Lisa, Baumann, Ana, Burns, Ebony, DeMartino, Terri, Jacobs, Sara, Khan, Hamda, Nwosu, Chinonyelum, Shah, Nirmish, Hankins, Jane S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578525/
https://www.ncbi.nlm.nih.gov/pubmed/36240004
http://dx.doi.org/10.2196/41415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578525/
https://www.ncbi.nlm.nih.gov/pubmed/36240004
http://dx.doi.org/10.2196/41415

Ejemplares similares